Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Rheumatology
Volume 2016, Article ID 9565427, 5 pages
http://dx.doi.org/10.1155/2016/9565427
Case Report

A Case of Acute Budd-Chiari Syndrome Complicating Primary Antiphospholipid Syndrome Presenting as Acute Abdomen and Responding to Tight Anticoagulant Therapy

Division of Rheumatology, Department of Internal Medicine, Tokai University School of Medicine, 142 Shimokasuya, Isehara 160-8582, Japan

Received 17 June 2016; Revised 16 August 2016; Accepted 21 August 2016

Academic Editor: Tsai-Ching Hsu

Copyright © 2016 Naofumi Chinen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. Uthman and M. Khamashta, “The abdominal manifestations of the antiphospholipid syndrome,” Rheumatology, vol. 46, no. 11, pp. 1641–1647, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Espinosa, J. Font, J. C. García-Pagan et al., “Budd-Chiari syndrome secondary to antiphospholipid syndrome: clinical and immunologic characteristics of 43 patients,” Medicine, vol. 80, no. 6, pp. 345–354, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. L. D. DeLeve, D.-C. Valla, and G. Garcia-Tsao, “Vascular disorders of the liver,” Hepatology, vol. 49, no. 5, pp. 1729–1764, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Rajesh, A. Mukund, and A. Arora, “Imaging diagnosis of splanchnic venous thrombosis,” Gastroenterology Research and Practice, vol. 2015, Article ID 101029, 29 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Martens and F. Nevens, “Budd-Chiari syndrome,” United European Gastroenterology Journal, vol. 3, no. 6, pp. 489–500, 2015. View at Publisher · View at Google Scholar
  6. H. Ferral, G. Behrens, and J. Lopera, “Budd-Chiari syndrome,” American Journal of Roentgenology, vol. 199, no. 4, pp. 737–745, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Senzolo, E. C. Cholongitas, D. Patch, and A. K. Burroughs, “Update on the classification, assessment of prognosis and therapy of Budd-Chiari syndrome,” Nature Clinical Practice Gastroenterology and Hepatology, vol. 2, no. 4, pp. 182–190, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. I. Castro, J. J. Ríos, N. Iniesta, I. Perez, A. Robles, and A. Gil, “Acute and fulminant Budd-Chiari syndrome in a well-anticoagulated patient with primary antiphospholipid syndrome,” Lupus, vol. 14, no. 12, pp. 979–980, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. S. S. Karti, M. Yilmaz, P. Kosucu et al., “Early medical treatment is life saving in acute Budd-Chiari due to polycythemia vera,” Hepato-Gastroenterology, vol. 50, no. 50, pp. 512–514, 2003. View at Google Scholar · View at Scopus
  10. NM. Kazzaz, WJ. McCune, and JS. Knight, “Treatment of catastrophic antiphospholipid syndrome,” Curr Opin Rherumatol, vol. 28, no. 3, pp. 218–227, 2016. View at Google Scholar
  11. European Association for the Study of the Liver, “EASL clinical practice guidelines: vascular diseases of the liver,” Journal of Hepatology, vol. 64, no. 1, pp. 179–202, 2016. View at Publisher · View at Google Scholar
  12. A. Plessier, A. Sibert, Y. Consigny et al., “Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome,” Hepatology, vol. 44, no. 5, pp. 1308–1316, 2006. View at Publisher · View at Google Scholar · View at Scopus